4 ms·
FDA approves Biogen’s Alzheimer’s drug, the first therapy in nearly two decades
- JamesBarney 5y agoDerek Lowe on Aducanumab. https://blogs.sciencemag.org/pipeline/archives/2021/06/03/a-brief-note-about-aducanumab https://blogs.sciencemag.org/pipeline/archives/2021/06/03/a-...
- 1-6 5y agoIs that why Eli Lilly, Roche, and Biogen’s stock pop?
- nyokodo 5y ago> Some doctors have said they won’t prescribe the drug if it does reach the market, because of the mixed data package supporting the company’s application. > Supporters, including advocacy groups and family members of those living with the disease desperate for a new treatment, have acknowledged the data isn’t perfect. However, they contend it could help some patients with Alzheimer’s, a progressive and debilitating disease. Not a shining endorsement of the drug’s efficacy, however I do hope it helps.
- noetic_techy 5y agoI thought they established a few years ago that amaloid-beta plaque removal has no effect and had to go back to the foundational theories on the disease itself. "Slows the clinical decline" ... sounds like a total dud to me.
- olliej 5y agoThe expert committee voted 8-1 against approving the drug, based on the company's own study showing negligible improvement.